StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / modulight.bio

Modulight Biotherapeutics

Modulight Biotherapeutics (modulight.bio): 2 changes recorded in its website history since December 2023. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. FundingBetween and

    Announced on its homepage: “(2025) Read More "Modulight Biotherapeutics announces $12 million seed funding for novel optogenic therapy to treat neurological disorder…”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. HeadlineBetween and
    BeforeHyper-sensitive synapse switches
    AfterRestoring Balance, Transforming Neurology

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 28 December 2023

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Hyper-sensitive synapse switches

ModuLight was founded to develop therapeutic treatments for severe neurological syndromes including drug-resistant focal epilepsy, Parkinson’s, and severe neuropathic pain syndromes using groundbreaki

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2024 – November 2026 · 4 captures · latest observed messagingRestoring Balance, Transforming Neurology

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 4 captures in this group
    • 20 July 2024 · Restoring Balance, Transforming Neurology archived page
    • 4 January 2025 · Restoring Balance, Transforming Neurology archived page
    • 24 October 2026 · Restoring Balance, Transforming Neurology archived page
    • 6 November 2026 · Restoring Balance, Transforming Neurology current websiteHistorical capture not publicly available
  2. December 2023 – February 2024 · 2 capturesHyper-sensitive synapse switches

    ModuLight was founded to develop therapeutic treatments for severe neurological syndromes including drug-resistant focal epilepsy, Parkinson’s, and severe neuropathic pain syndromes using groundbreaki

    This wording observed 1 February 2024.

    archived page
    Inspect 2 captures in this group
    • 28 December 2023 · Hyper-sensitive synapse switches archived page
    • 1 February 2024 · Hyper-sensitive synapse switches archived page

Cite this record

StartupHistory, “Modulight Biotherapeutics” company record, https://startuphistory.org/c/modulight.bio

Machine-readable: /c/modulight.bio.json. How changes are found: method.